Monitor for actual sales by RA Capital, which could create downward pressure on the stock. The shelf registration provides Equillium with flexibility for future capital raises, but current cash runway into 2029 suggests no immediate funding need. Watch for warrant exercises which would bring minimal additional cash ($1,770) to the company.
Price Chart
Executive Summary
Equillium filed an S-3 shelf registration to allow RA Capital Management to resell up to 18.88 million shares, including 17.7 million from pre-funded warrants, from a recent $35 million private placement. The company will not receive proceeds from these sales, but the registration supports future capital raising. This follows strong financial positioning, with cash expected to fund operations into 2029.
Key Financial Metrics
Key Facts
- S-3 filing enables resale of 18,878,101 shares by RA Capital Healthcare Fund, L.P., including 17,698,593 shares issuable upon exercise of pre-funded warrants
- Shares originated from a $35 million private placement completed March 13, 2026, at $1.854 per share
- Equillium will not receive any proceeds from the resale of these shares
- Company had $30.3 million in cash as of December 31, 2025, with runway expected into 2029 including the $35 million financing
- Recent insider activity shows 2 sells totaling $663K in the past 30 days
Financial Impact
Potential dilution of 29.8% of current shares outstanding (18.88M shares offered vs 63.23M shares outstanding)
Risk Factors
- Significant share overhang from warrant exercises could pressure stock price
- Potential perception of insider lack of confidence given recent insider selling
- Future offerings under this shelf could lead to additional dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-145746 |
| Document: d116924dex43.htm | 0001193125-26-145746 |
| Document: d116924dexfilingfees.htm | 0001193125-26-145746 |
| Document: d116924dex51.htm | 0001193125-26-145746 |
| Document: d116924dex231.htm | 0001193125-26-145746 |
| Document: d116924dex232.htm | 0001193125-26-145746 |
| Document: 0001193125-26-145746-index-headers.html | 0001193125-26-145746 |
| Document: 0001193125-26-145746-index.html | 0001193125-26-145746 |
| Document: 0001193125-26-145746.txt | 0001193125-26-145746 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $1.29 | awaiting T+60 | — | $1.25 (+3.10%) |
Oct 26, 2026 today | Press Release | $1.12 | awaiting T+60 | — | $1.25 (+11.58%) |
Oct 5, 2026 21d ago | 8-K | $1.42 | awaiting T+60 | — | $1.25 (−11.97%) |
Oct 5, 2026 21d ago | Press Release | $1.42 | awaiting T+60 | — | $1.25 (−11.97%) |
Sep 29, 2026 27d ago | Press Release | $1.63 | awaiting T+60 | — | $1.25 (−23.08%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.81 $2.21 | ▼ −21.35% | ▼ −25.75% | $1.25 (−55.52%) |
Jun 5, 2026 20w ago | Insider Cluster | $2.77 $2.21 | ▲ +20.40% | ▲ +23.45% | $1.25 (+54.87%) |
May 29, 2026 21w ago | Insider Cluster | $3.08 $2.18 | ▼ −29.22% | ▼ −30.45% | $1.25 (−59.42%) |
May 20, 2026 22w ago | Press Release | $2.21 | awaiting T+60 | — | $1.25 (−43.44%) |
Apr 17, 2026 27w ago | EFFECT | $2.05 $2.76 | ▲ +34.63% | ▲ +28.49% | $1.25 (−39.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers